After attending this event, the learners will be able to:

• Define hematopoietic progenitor cell transplantation (HPCT) and hematopoetic progenitor cells
• Describe the types of HPCT and HPC sources and indications for HPCT
• Describe the history of HPCT
• Describe the indication and usage of mesenchymal cells
• List indications for HPCT and best explain the indications to patients and families
• Describe hematopoetic progenitor cells sources
• Describe advances in new therapies with dendritic cell and immune therapies
• Define human leukocyte antigen (HLA)
• Describe genetic inheritance of HLA and better understand HLA typing
• Describe the process of donor identification and selection for allogenic marrow, peripheral blood stem cell (PBSC), and cord blood transplant
• Identify specimens used for HLA typing
• Discuss the purpose of pre-transplant evaluation for HPCT patients
• Describe the components of a patient evaluation for potential HPCT to patient and families
• Describe the HPC donor evaluation process
• Identify safety issues in pediatric apheresis and when to involve the professional practice team for additional support
• Identify potential barriers to HPCT